President Donald Trump's financial dealings are under scrutiny. A recent filing shows numerous stock transactions, totaling over 1,000, occurred in June. These transactions involve various companies, including those in the energy sector and pharmaceutical industry.

The filing, submitted to the Office of Government Ethics, reveals purchases and sales of stock in companies such as Eli Lilly and Merck. Other targeted industries include artificial intelligence, with companies like Nvidia.

Further details about these transactions are available, but it is known that they have raised questions about potential personal profits from presidential policies.